La. Admin. Code tit. 46 § LXXXV-1225

Current through Register Vol. 50, No. 9, September 20, 2024

Section LXXXV-1225 - Responsibilities of a Lead CAET

A. Designation

1. Pursuant to R.S. 37:1552(4), a person seeking designation as a Lead CAET must submit the following to the board:

a. a completed application form approved by the board which shall be sworn to and notarized before a Louisiana notary public;

b. a copy of his current Louisiana state controlled dangerous substances license;

c. a copy of his current registration with the U.S. Drug Enforcement Administration;

d. documentation from the sponsor of a board-approved chemical capture training course that:

i. he has completed the chemical capture training course; or

ii. until December 31, 2000, if a designee applicant completed a chemical capture training course prior to August 1, 2000, he may submit documentation of such completion along with information concerning the content of the course to the board; the board may approve the course and accept it as sufficient to meet the requirements of R.S. 37:1552(4)(c).

B. Legal Drugs. Pursuant to R.S. 37:1556.B, those controlled substances a Lead CAET may legally order and maintain for the sole purpose of restraining, capturing and euthanizing animals shall be limited to the following:

1. sodium pentobarbital at a minimum strength of six grains per milliliter;

2. tiletamine hydrochloride and zolazepam hydrochloride; and

3. ketamine hydrochloride.

C. Providing Chemical Capture Drugs

1. A Lead CAET shall provide chemical capture drugs only to persons who have completed a board-approved training course in the use of chemical capture drugs.

2. Prior to transferring chemical capture drugs to a person who has completed a board-approved training course in the use of chemical capture drugs, a Lead CAET shall have and maintain on file documentation from the sponsor of the board-approved course that the person completed the course. Until December 31, 2000, if a person to whom the Lead CAET provides chemical capture drugs completed a chemical capture training course prior to August 1, 2000, the Lead CAET may submit documentation of such completion along with information concerning the content of the course to the board. The board may approve the course and accept it as sufficient to meet the requirements of R.S. 37:1556.B.(4).

3. Prior to ordering, maintaining, or providing any controlled substance under his own authority to another person, the lead CAET must be registered with the Drug Enforcement Administration (DEA) and licensed by the state controlled dangerous substances program at the shelter location where the drugs will be stored and administered.

4. The Lead CAET must maintain and store the controlled substances allowed for use under §1225. B in a manner which meets or exceeds the requirements of all federal or state drug enforcement agencies, including storage of controlled substances in a securely locked, substantially constructed cabinet and the keeping of a perpetual inventory as required by LAC 48:I.Chapter 39.

5. Use of controlled substances allowed under §1225. B shall be documented to include, but not limited to:

a. date of each use of the drug;

b. species of animal;

c. estimated weight of animal;

d. dose administered;

e. name of animal control officer to whom the drug was transferred and who administered the drug;

f. a perpetual (running) inventory of the drug present at the facility; and

g. both the Lead CAET and person to whom the drug is transferred shall sign a drug sign-out document each time the drug is transferred for use.

6. The Lead CAET shall review each use of the controlled substances allowed under §1225. B and the Lead CAET shall initial the usage log entries to indicate this review. A review of the usage logs shall be made at least quarterly and the quantities of drug used and on hand shall be tallied and authenticated. Any variance shall be noted in the log and steps should be taken and documented to correct the problem.

7. Any removal of the controlled substances allowed under §1225. B from the securely locked, substantially constructed cabinet shall be in minimal amounts, shall be maintained in a locked container when not in use, and shall be documented in a manner to include, but not be limited to:

a. a signed log indicating the person removing the drug;

b. the date on which the drug was removed;

c. an accounting for all drug used and the amount returned;

d. the date on which the remaining drug was returned and the signature of the person returning it.

8. This Section does not pertain to any drug(s) listed in any DEA classification schedule (also known as controlled drugs) or state of Louisiana classification schedule, except those allowed under §1225 B

D. Failure of a Lead CAET to comply with any and all provisions of §1223 and §1225 shall be considered a violation of the rules of professional conduct within the meaning of R.S. 37:1554.A.(12).

La. Admin. Code tit. 46, § LXXXV-1225

Promulgated by the Department of Health and Hospitals, Board of Veterinary Medicine, LR 26:320 (February 2000).

AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1558.